<DOC>
	<DOCNO>NCT00527163</DOCNO>
	<brief_summary>This study , conduct NIH , University Bamako Mali , Africa , Tulane University examine relationship hemolysis ( breakdown red blood cell ) , nitric oxide ( gas important regulating blood vessel dilation blood flow ) pulmonary hypertension patient malaria . Malaria among lead cause death many world poor country . It cause parasite transmitted human mosquito . Malian child age 1-5 year eligible participation study . They include child asymptomatic infection , uncomplicated disease , severe disease . Uninfected control also include . Upon enrollment , participant medical history physical examination , echocardiogram ( ultrasound test heart function ) blood test . In addition , participant ( infected child control ) repeat evaluation healthy , approximately 7 to10 day follow successful therapy .</brief_summary>
	<brief_title>Role Nitric Oxide Malaria</brief_title>
	<detailed_description>Malaria among lead infectious cause death many world poor country . This parasitic mosquito-borne illness produce massive hemolysis many infected human host . While much know parasite replication cytoadherence , little known impact hemolysis per se vascular tone endothelial function . Crossing number medical discipline beyond scope malaria , intrigue new research inherit hemolytic disorder sickle cell disease ( SCD ) provide clue pathogenic mechanism may relevant malaria . Dr. Gladwin ( NHLBI ) colleague characterize mechanism disease , hemolysis-associated endothelial dysfunction , red blood cell hemoglobin spill plasma reacts oxidatively destroy nitric oxide ( NO ) . Additionally , erythrocyte arginase I release plasma catabolizes arginine , substrate endothelial NO synthesis . As result , profound reduction NO bioavailability produce vasomotor instability , oxidant stress , inflammation , endothelial adhesion molecule expression , activation tissue factor , platelet aggregation . Consistent share mechanism , pathway find activated malarial infection . Chronic hemolysis hemoglobinopathy also lead disease syndrome , hemolysis associate pulmonary hypertension , develop chronic hereditary acquire hemolytic condition associate excessive morbidity mortality . Despite recent appreciation mechanism , one study find literature evaluate pulmonary hypertension human malaria . This protocol therefore aim evaluate mechanism govern interrelationship among malaria , intravascular hemolysis , NO bioavailability , endothelial function , pulmonary hypertension , evolutionarily select host polymorphism regulate host response hemolysis . We correlate clinical observation field laboratory assays hemolysis nitric oxide bioavailability relate scavenge cell-free hemoglobin arginine catabolism . Using candidate gene approach , identify selectively characterize polymorphism gene important endothelial function , vascular inflammation disease phenotype . Finally , characterization mechanism malaria may catalyze development novel therapy target pathway , sodium nitrite , inhale nitric oxide gas , and/or recombinant haptoglobin infusion . This international collaboration scientist NIH , University Bamako , Tulane University provide exclusive opportunity rapid transfer appropriate technology expertise relevant provision high quality care malaria patient Mali world .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>ELIGIBILITY CRITERIA : Malian child age 15 year eligible participation study . We require parent legally authorize guardian present enrollment provide consent . Given eligibility age child , incipient maturity intelligence permit direct participant assent . INCLUSION CRITERIA : Inclusion criterion Healthy Uninfected control : Malian child age 15 year , regardless gender ethnicity . A peripheral blood smear negative presence Plasmodium falciparum . Temperature less equal 37.5 degree Celsius . The child parent guardian must present consent enrollment . Inclusion criterion Asymptomatic Parasitemia control : Malian child age 15 year , regardless gender ethnicity . Plasmodium falciparum microscopically visualize blood smear , asexual parasite density great equal 2,000/microL blood less 500,000/microL blood . Temperature less equal 37.5 degree Celsius . The child parent guardian must present consent enrollment . Inclusion criterion Uncomplicated Malaria case : Malian child age 15 year , regardless gender ethnicity . Plasmodium falciparum microscopically visualize blood smear , asexual parasite density great equal 2,000/microL blood less 500,000/microL blood . Signs symptom malaria ( e.g . headache , body ache , malaise ) . Temperature 37.6 39.9 degree Celsius , OR history fever . The child parent guardian must present consent enrollment . Inclusion criterion Severe Malarial Anemia case : Malian child age 15 year , regardless gender ethnicity . Plasmodium falciparum microscopically visualize blood smear , asexual parasite density great equal 2,000/microL blood less 500,000/microL blood . Hemoglobin le 5 g/dL , hemoglobin 5.06.9 g/dL accompany respiratory distress . The child parent guardian must present consent enrollment . EXCLUSION CRITERIA : Exclusion criterion Healthy Uninfected control : Signs symptom consistent malaria ( e.g . headache , body ache , malaise ) . Temperature great 37.5 degree Celsius , OR history fever . History antimalarial medication use within 2 week prior enrollment . Transfusion blood product within 2 week prior enrollment . Signs symptoms active infectious disease , whether bacterial , viral , parasitic nature . Coexisting severe chronic medical condition ( e.g . bacteremia , meningitis , kwashiorkor , renal failure , recent trauma , etc. ) . Exclusion criterion Asymptomatic Parasitemia control : Signs symptom consistent malaria ( e.g . headache , body ache , malaise ) . Temperature great 37.5 degree Celsius , OR history fever . History antimalarial medication use within 2 week prior enrollment . Transfusion blood product within 2 week prior enrollment . Signs symptoms active infectious disease , whether bacterial , viral , parasitic nature . Coexisting severe chronic medical condition ( e.g . bacteremia , meningitis , kwashiorkor , renal failure , recent trauma , etc. ) . Exclusion criterion Uncomplicated Malaria case : Any criterion severe malaria , include : CEREBRAL MALARIA Coma ( Blantyre coma score less equal convulsion [ witness investigator ] ) . SEVERE ANEMIA ( hemoglobin le 5 g/dL ) . RESPIRATORY DISTRESS ( respiratory rate great 40 2 following : nasal flaring , intercostal indrawing , subcostal recession grunt ) . HYPOGLYCEMIA ( blood glucose less 40 mg/dL ) . RENAL FAILURE ( urine output 24 hour ) . JAUNDICE/ICTERUS . SEVERE PROSTRATION ( great 7 month old , inability sit drink ) . HYPERPARASITEMIA ( asexual parasite density great equal 500,000/microL blood ) . SHOCK ( systolic blood pressure le 50 mmHg , rapid pulse , cool extremity ) . REPETITIVE VOMITING cessation eat drinking . HYPERPYREXIA ( temperature great equal 40 degree Celsius ) . Etiologies febrile illness ( e.g . respiratory tract infection , cellulitis ) clinical examination attributable malaria . Coexisting severe chronic medical condition ( e.g . bacteremia , meningitis , kwashiorkor , renal failure , recent trauma , etc . ) unrelated P. falciparum infection . Transfusion blood product within 2 week prior enrollment . Exclusion criterion Severe Malarial Anemia case : Evidence CEREBRAL MALARIA . Coma ( Blantyre coma score less equal 2 ) , Convulsions ( witnessed investigator ) . Evidence HYPOGLYCEMIA . Blood glucose less 40 mg/dL . Evidence HYPERPARASITEMIA . Asexual parasite density great equal 500,000/microL blood . Evidence SHOCK . Systolic blood pressure le 50 mmHg sign hypoperfusion circulatory collapse ( e.g . rapid pulse , cool extremity ) . Etiologies febrile illness ( e.g . respiratory tract infection , cellulitis ) clinical examination attributable malaria . Coexisting severe chronic medical condition ( e.g . bacteremia , meningitis , kwashiorkor , renal failure , recent trauma , etc . ) unrelated P. falciparum infection . Transfusion blood product within 2 week prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 30, 2015</verification_date>
	<keyword>Echocardiogram</keyword>
	<keyword>Endothelial Dysfunction</keyword>
	<keyword>Malaria</keyword>
	<keyword>Mali</keyword>
	<keyword>Screening</keyword>
</DOC>